Berlin, August 15, 2017. Digital Health platform Qunomedical (formerly Junomedical) today announced its funding round of $2 million and a new brand name. The platform provides patients with access and independent information on the world’s best doctors and hospitals. Qunomedical is the only provider to vet medical providers by means of a multi-stage quality algorithm developed by medical practitioners together with data scientists to list only accredited clinics. Dr. Sophie Chung, doctor and founder of Qunomedical, pursues the vision of breaking down the barriers to affordable, short-term and complex medical treatments for patients all over the world.
Investors like Kima Ventures from Paris are joining Project A from Berlin and 500 Startups from San Francisco, thereby strengthening the company’s international focus. “Digital health is one of our focus areas and we are happy to support companies like Qunomedical which are pushing the boundaries in the industry,” says Anton Waitz, Partner at Project A. “Since day one we believed in Sophie’s vision and it’s great to see the company grow in Germany and internationally.”
Launched in April 2016, the platform currently works with over 4,000 patients per month and partners with internationally certified clinics in 25 countries. Qunomedical shows monthly growth rates of 23% since its launch. In the first twelve months the company focussed on English-speaking countries. The most recent financial boost will help Qunomedical strengthen its presence in the English-speaking market and expand its offering in German-speaking markets. Jean de La Rochebrochard, Partner at Kima Ventures: “Qunomedical makes healthcare accessible to more patients by connecting them with the right doctors who can meet their needs in the best conditions. It’s very exciting to be part of this journey!”
The new name is another step to strengthen its international brand recognition as a leading patient-centric platform. According to Dr. Sophie Chung, CEO and founder of Qunomedical, this has been a strategic decision: “The name represents the next step in our company history. Our product has evolved over the last 1.5 years. With the financing round, we are now focusing on sustainable growth. The launch of the German website and potential trademark conflicts in the US were contributing factors for this decision.”
The new name reflects the deepened understanding about the patients who turn to Qunomedical. Derived from the Latin verb quaerere (engl.: search, seek), Qunomedical stands for the empowered patient, who is looking for the best possible medical care. The new logo visualizes the vision to simplify access to healthcare and focus on the patient. The magnifying glass reflects the company’s mission to make the medical options visible to patients worldwide. Most importantly, Qunomedical’s fundamental belief that everybody in this world deserves easy access to the best possible care remains, and continues to shape its mission.